Speclipse, Inc., is the medical device developer of the world’s first cancer diagnostic solution based on laser-induced plasma spectroscopy (LIPS) and artificial intelligence (AI) technology. Our core technology, Spectra-Scope®, embodies a real-time, non-invasive, in-vivo diagnosis of skin cancers without compromising efficacy and accuracy while preventing unnecessary biopsies.
We are committed to providing innovative medical technology to assist in challenging diagnosis cases—and it is our mission to continue to improve our technology so physicians can spend more time focusing on their patients and making accurate diagnoses.
Company Details
- Employees
- 11
- Founded
- 2015
- Address
- 310 De Guigne Dr, Sunnyvale,california 94085,united States
- Phone
- 82-31-698-2269
- ce****@****pse.com
- Industry
- Medical Device
- Website
- speclipse.com
- Keywords
- Skin Cancer Awareness, Skin Cancer Prevention, Skin Cancer Screening, Dermatology, Laser Treatment, Laser-Induced Plasma Spectroscopy, Artificial Intelligence, Medical Technology, Medical Device Development, Cancer Diagnostic Technology.
- HQ
- Sunnyvale, California
Speclipse, Inc. Questions
Speclipse, Inc.'s helpline number is 82-31-698-2269
Speclipse, Inc.'s website is speclipse.com
Speclipse, Inc.'s LinkedIn profile is https://www.linkedin.com/company/speclipse-inc.
Speclipse, Inc. has
11 employees.
View email and phone details for 11
employees at Speclipse, Inc..
Speclipse, Inc.'s industry is
Medical Device
Speclipse, Inc.'s top competitors are
Toosonix,
Elite-Prp,
Lifelinq Ai,
Bap Medical Ireland,
Meldermatix,
Dropwise Technologies Corp.,
Econsultantclinic,
1366 Technologies Inc,
Carbonblack,
No Trace Lasers.
Speclipse, Inc.'s support email address is ceo@speclipse.com
Speclipse, Inc.'s categories are Medical Device
Speclipse, Inc.'s founding year is 2015
